2Lansang MC, Hollenberg NK. Renal perfusion and the renal hemodynamic response to blocking the rennin system in diabetes.Are the forces leading to vasodilation and vasoconstriction linked.Diabetes, 2002,51: 2025-2028.
3Miller JA, Curtis JR, Sochett EB. Relationship between diurnal blood pressure, renal hemodynamic function, and the renninangiotensin system in type 1 diabetes. Diabetes, 2003, 52:1806-1811.
4Lane PH. Diabetic kidney disease: impact of puberty. Am J Physiol Renal Physiol, 2002,283: F589-F600.
5White KE, Bilous RW, Marshall SM, et al. Podocyte number in normotensive type 1 diabetic patients with albuminuria. Diabetes,2002; 51: 3083-3089.
6Kveder R, Kajtna KM, Rott T, et al. Nephrotic syndrome in patients with diabetes mellitus is not always associated with diabetic nephropathy. Nephrol Dial Transplant, 2001, 16 Suppl:86-87.
7Haneda M, Koya D, Isono M, et al. Overview of glucose signaling in mesangial cells in diabetic nephropathy. J Am Soc Nephrol,2003,14: 1374-1382.
8Evans JL, Goldfine ID, Maddux BA, et al. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2diabetes. Endocrine Reviews, 2002,23: 599-622.
9Limaye PV, Raghuram N, Sivakami S. Oxidative stress and gene expression of antioxidant enzymes in the renal cortex of streptozotocin-induce diabetic rats. Mol cell biochem,2003,243:147-152.
6Frank P,Kay H,Beate K,et al.Rosiglitazone Improves Glomerular Hyperfihration,Renal Endothelial Dysfunction,and Microalbuminuria of Incipient Diabetic Nephlopathy in Patients.Diabetes,2005,54(7):2206-2211.
7Sarafidis P, Lasaridis A, Nilsson P, et al. The elect of rosiglitazone on urine albumin excretion in patients with type 2diabetes mellitus and hypertension[J]. Am J Hypertens, 2005, 18 (2Pt1) : 227-234.
8Frank P, Kay H, Beate K, et al. Rosiglitazone Improves Glomerular Hyperfihration, Renal Endothelial Dysfunction, and Microalbuminuria of Incipient Diabetic Nephlopathy in Patients[J]. Diabetes. 2005. 54 (7): 2206-2211.
9Pistrosch F, Herbrig K, Kindel B, et al. Rosiglitazone improves glomerular hyperfihratian, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients [ J ]. Diabetes, 2005 ; 54 ( 7 ) : 2206 -11.
10Sarafidis P, Lasaridis A, Nilsson P, et al. The effect of rosiglitazone on urine albumin excretion in patients with type 2 diabetes mellitus and hypertension [ J 1. Am J Hypertens ,2005 ; 18 (2Pt1) :227-34.